Weekly Briefing for November 8 to 14, 2026

From Physician in the Loop: Pathology · 3:01

Show by Nomad Medical

The Food and Drug Administration (FDA) issued final guidance on Nov. 9 on validating in vitro diagnostic tests for emerging pathogens during a Section 564 declared emergency, replacing a January 2025 draft.Waters announced 510(k) clearance of two BD OneFlow flow cytometry tests for B-cell lymphoma, and a National Kidney Foundation (NKF) workshop report said urinary albumin should generally be preferred over total protein.Read this week's roundup and its sources: https://physicianintheloop.org/specialties/pathology/2026-11-08/Get this roundup by email, freeThe voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

More episodes of Physician in the Loop: Pathology

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.